CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | -72.7% | 16,735 | -26.4% | 0.00% | – |
| Q3 2018 | $11,000 | -42.1% | 22,735 | -36.7% | 0.00% | -100.0% |
| Q2 2018 | $19,000 | -87.5% | 35,935 | -44.9% | 0.00% | -75.0% |
| Q1 2018 | $152,000 | -19.1% | 65,270 | -0.9% | 0.00% | -20.0% |
| Q4 2017 | $188,000 | +9.3% | 65,870 | +9.8% | 0.01% | 0.0% |
| Q3 2017 | $172,000 | -27.4% | 59,995 | -37.5% | 0.01% | -28.6% |
| Q2 2017 | $237,000 | -34.9% | 95,946 | -4.9% | 0.01% | -30.0% |
| Q1 2017 | $364,000 | -12.7% | 100,871 | -14.2% | 0.01% | -16.7% |
| Q4 2016 | $417,000 | -24.7% | 117,580 | -14.2% | 0.01% | -25.0% |
| Q3 2016 | $554,000 | -25.0% | 137,087 | -18.6% | 0.02% | -27.3% |
| Q2 2016 | $739,000 | -2.5% | 168,358 | -16.0% | 0.02% | -4.3% |
| Q1 2016 | $758,000 | -76.5% | 200,442 | -2.7% | 0.02% | -76.0% |
| Q4 2015 | $3,231,000 | +74.3% | 206,062 | +17.2% | 0.10% | +71.4% |
| Q3 2015 | $1,854,000 | -57.2% | 175,864 | +2.4% | 0.06% | -53.3% |
| Q2 2015 | $4,331,000 | -16.2% | 171,728 | -7.4% | 0.12% | -14.9% |
| Q1 2015 | $5,170,000 | +36.3% | 185,477 | -10.8% | 0.14% | +29.4% |
| Q4 2014 | $3,793,000 | +16.4% | 207,858 | -17.3% | 0.11% | +12.4% |
| Q3 2014 | $3,258,000 | -14.3% | 251,382 | +7.9% | 0.10% | -14.9% |
| Q2 2014 | $3,803,000 | +14.5% | 233,012 | +24.0% | 0.11% | +14.0% |
| Q1 2014 | $3,322,000 | +27.8% | 187,981 | +75.2% | 0.10% | +20.5% |
| Q4 2013 | $2,599,000 | -32.1% | 107,318 | -0.7% | 0.08% | -38.5% |
| Q3 2013 | $3,829,000 | +106.2% | 108,076 | -9.2% | 0.14% | +87.5% |
| Q2 2013 | $1,857,000 | – | 118,979 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |